Dose: 200mg TDS for 1 week then 200mg BD for
Anti-Arrhythmics
1 week then 200mg OD
Class 1A Disopyramide MHRA/CHM (2015): risk of severe bradycardia
Class 1B Lidocaine and heart block when antivirals (sofosbuvir,
Class 1C Flecainide, Propafenone daclatasvir) are used with AD
Class 3 Amiodarone, Dronedarone
SEs: arrhythmias, pancreatitis, SCARs,
Disopyramide (Rythmodan) photosensitivity, altered taste
M: hyperglycaemia, hypotension, ventricular Corneal microdeposits – reversible on
tachycardia and fibrillation, torsades de pointes, withdrawal of Tx. If vision is impaired or optic
serum potassium neuritis/neuropathy occurs, discontinue to
prevent blindness
Lidocaine
Thyroid function – AD contains iodine.
Methaemoglobinaemia – can be treated with Hypothyroidism can be treated with
methylthioninium chloride replacement therapy without stopping AD
Flecainide Hepatotoxicity – discontinue if severe liver
function abnormalities occur
Dose adjustment – reduce dose by ½ when
using with amiodarone Pulmonary toxicity – report any new or
progressive shortness of breath or cough
Adenosine
Monitoring:
Indication: rapid reversion to sinus rhythm 1. TFTs – before Tx then every 6 months.
SEs: discontinue if chest pain or hypotension T4 (thyroxine) may be high in the absence
occurs, flushing, throat discomfort, AV block of hyperthyroidism, hence measure T3 (tri-
iodothyronine), T4 and TSH (thyroid-
Bradycardia – discontinue stimulating hormone).
Respiratory failure – discontinue Raised T3 and T4 with a low or undetectable
TSH = thyrotoxicosis
Dronedarone (Multaq) 2. LFTs – before Tx then every 6 months
3. Serum K+
Liver injury – discontinue Tx if 2 consecutive
4. Chest x-ray
alanine aminotransferase conc. exceed 3 times
upper limit of normal With antivirals – monitor closely. Pts at high
risk of bradycardia should be monitored
Heart failure – discontinue if heart failure or left
continuously for 48 hours after starting Tx.
ventricular systolic dysfunction develops
Advice:
Pulmonary toxicity – discontinue if dyspnoea or
1. Use a wide-spectrum sunscreen to protect
dry cough develops
against both long-wave UV and visible light
M: heart failure, ECG, serum creatinine, LFTs 2. With antivirals – report ASAP any SOB, light-
headedness, palpitations, fainting, unusual
Advice: report signs of heart failure and hepatic
tiredness or chest pain
disorders
, Chapter 2 – Cardiovascular System
Anti-Arrhythmics BLEEDING DISORDERS
Sotalol (Beta-Cardone, Sotacor) Anti-Fibrinolytics
Safety information – may prolong the QT
Tranexamic acid (Cyklokapron)
interval. Avoid hypokalaemia in Pts.
Indications: menorrhagia, local fibrinolysis,
X: long QT syndrome
epistaxis, hereditary angioedema
SEs: chest pain, sexual dysfunction, torsades de
X: H/O convulsions, thromboembolic disease
pointes (increased risk in females)
!: irregular menstrual bleeding (establish cause
M: correct hypokalaemia, hypomagnesaemia
before initiating therapy), haematuria, oral
Cardiac Glycosides contraceptives (risk of thrombosis)
SEs: diarrhoea (reduce dose)
Digoxin (Lanoxin)
Colour vision changes – discontinue
Indications: rapid digitalisation for AV or flutter,
heart failure (for Pts in sinus rhythm) Menorrhagia – exclude structural or histological
causes or fibroids
Dose adjustments – reduce dose by ½ with
concurrent use of amiodarone or quinine Coagulation Proteins
Dose conversion – reduce dose if digoxin has
Dried Prothrombin Complex
been given in the preceding 2 weeks. When
switching from IV to oral route, increase dose Indications: haemorrhage and major bleeding
by 20-33% to maintain serum concentration in warfarin Pts following phytomenadione
X: constrictive pericarditis, hypertrophic X: angina, H/O heparin-induced
cardiomyopathy, heart block, 2nd block AV thrombocytopenia, recent MI
block, supraventricular arrhythmias, ventricular
tachycardia or fibrillation Plasma Products
! (risk of toxicity): hypercalcaemia, Fresh Frozen Plasma
hypokalaemia, hypomagnesaemia, hypoxia,
recent MI, severe respiratory disease, sick sinus Indications: replacement of coagulation factors
syndrome, thyroid disease and major bleeding in warfarin Pts following
phytomenadione
SEs: arrhythmias, cardiac conduction disorder,
diarrhoea, eosinophilia, vision disorders, !: severe protein S deficiency
depression, dizziness
Calcium Channel Blockers
Monitoring:
1. Plasma-digoxin concentration – take blood Nimodipine (Nimotop)
6 hours post dose Indications: subarachnoid haemorrhage
2. Serum electrolytes
3. Renal function X: unstable angina, within 1 month of MI
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller anmoll. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for $9.82. You're not tied to anything after your purchase.